Alpine Immune Sciences, Inc.Seattle, WA, United States
Clinical Biomarker Scientist at Alpine Immune Sciences.
2350: Upregulation of Both APRIL and BAFF in Systemic Lupus Erythematosus Suggests Non-Redundant Roles, Further Revealed by Dual Inhibition with Povetacicept (ALPN-303; TACI vTD-Fc)
Tuesday, November 14, 20239:00 AM – 11:00 AM PT
Disclosure information not submitted.
